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K-Conotoxin PVTIA (k-PVIIA), a  27-am ino acid  p ep tide  
w ith  th re e  d isu lfide cross-links, iso la ted  from  th e  venom  
of Conus purpurascens, is  th e  firs t conopep tide  show n to 
in h ib it th e  S h a ker  K+ ch an n el (Terlau, H., Shon, K., 
G rilley, M., Stockei', M., S tuhm er, W., an d  O livera, B. M.
(1996) N ature  381, 148-151). R ecently , tw o g roups in d e­
pend en tly  d e te rm in ed  th e  so lu tion  s tru c tu re  fo r 
k-PVIIA u s in g  NMR; a lthough  th e  s tru c tu re s  rep o rted  
w ere sim ilar, tw o m utua lly  exclusive m odels fo r th e  in ­
te ra c tio n  of th e  p ep tide  w ith  th e  S h a ker  ch an n el w ere 
p roposed . We c a rr ie d  ou t a  s tru c tu re /fu n c tio n  analysis 
of k-PVIIA, w ith  a lan in e  su b s titu tio n s  fo r all am ino ac­
ids p o stu la ted  to  be key  re s id u es  by b o th  groups. O ur 
d a ta  a re  co n sis ten t w ith  th e  c ritica l dyad  m odel devel­
oped  by M enez an d  co-w orkers (D auplais, M., Lecoq, A., 
Song, J ., C otton, J ., Jam in , N., G ilquin, B., R oum estand , 
C., V ita, C., de M edeiros, C., Row an, E. G., H arvey, A. L., 
an d  M enez, A. (1997) J. Biol. Chem. 272, 4802-4809) fo r 
po lypep tide an tag o n is ts  of K + channels. In  th e  case of 
k-PVIIA, Lys7 an d  P h e 9 a re  essen tia l fo r ac tiv ity  as p re ­
d ic ted  by  S avarin  et al. (Savarin, P., G uenneugues, M., 
G ilquin, B., L am thanh , H., G asparin i, S., Z inn-Justin , S., 
an d  M enez, A. (1998) Biochem istry  37, 5407-5416); these  
w ork ers  also co rrec tly  p red ic ted  an  im p o rtan t ro le  fo r 
Lys25. Thus, a lthough  K-conotoxin PVIIA h as  no obvious 
sequence hom ology to  po lypep tide tox ins from  o th e r 
venom ous an im als th a t  in te ra c t w ith  voltage-gated  K + 
channels, th e re  m ay be convergen t fu n c tiona l fea tu re s  
in  d iverse  K+ ch an n e l po lypep tide  an tagon ists .
The venomous cone snails have evolved a neuropharmaco- 
logical strategy largely based on highly sophisticated peptide 
ligands, the conotoxins (for reviews see Refs. 3 and 4). Partic­
ular molecular forms of both voltage-gated and ligand-gated 
ion channel families are targets of peptides belonging to spe­
cific conotoxin families. Among the ligand-gated ion channels 
that Conus peptides are known to inhibit are nicotinic acetyl­
choline receptors (5), iV-methyl-D-aspartate receptors (3, 6, 7) 
and 5HT3 receptors (8). In the voltage-gated ion channel su­
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perfamily, Conus peptides specific for various subtypes of cal­
cium channels (9) and sodium channels (10) have been de­
scribed. K-Conotoxin PVIIA from the venom of the Eastern 
Pacific fish-hunting species Conus purpurascens was the first 
conopeptide described tha t targets voltage-gated potassium 
channels (1, 11).
The role of K-conotoxin PVIIA in prey capture has been 
established (1); this peptide is key to the very rapid immobili­
zation of fish prey by C. purpurascens. This cone species uses 
the following two groups of toxins to affect different physiolog­
ical programs in the prey after venom injection: a very rapid 
excitotoxic shock and a slower onset but irreversible neuromus­
cular block. K-Conotoxin PVIIA plays a role in the initial exci­
totoxic shock response to venom injection; in combination with 
S-conotoxin PVIA (which delays inactivation of voltage-gated 
sodium channels), an immediate tetanic-like immobilization is 
elicited upon injection into fish.
The voltage-gated potassium channel Shaker, cloned from 
Drosophila melanogaster, is sensitive to K-conotoxin PVIIA (1). 
Electrophysiological characterization of the interaction of 
k-PVIIA1 with chimeras between the Shaker channel and a 
K-conotoxin-insensitive potassium channel from ra t brain (Kv­
l .l )  demonstrated tha t the binding determinants on Shaker 
were in the pore region of the channel, presumably at the 
extracellular face (11).
Recently, two different groups published structures for 
k-PVIIA, determined on the basis of multidimensional NMR 
techniques (12, 13); the structures were generally similar. 
However, the interpretation of likely mechanisms of the molec­
ular orientation of K-conotoxin PVIIA in the channel mouth 
suggested by the two groups, based on the structural informa­
tion, differed. Scanlon et al. (12) hypothesized that k-PVIIA 
interaction with the Shaker potassium channel might be 
strongly analogous to the charybdotoxin -Shaker channel inter­
action (for a review of the charybdotoxin family, see Refs. 14 
and 15). Although the two toxins share little primary sequence 
homology, it was suggested that specific amino acids in the 
K-conotoxin (His11, Arg18, Lys19, and Arg22) might correspond 
to four key residues in charybdotoxin (Lys11, Arg25, Lys27, and 
Arg31). In contrast, Savarin et al. (13) suggested that a dyad 
motif of lysine and an aromatic residue (Lys7 and Phe9 or 
Phe23) shared by a variety of unrelated toxins that inhibit 
voltage-gated potassium channels, including charybdotoxin 
from scorpion and BgK from sea anemone (2), would be a key 
determinant for K-conotoxin PVIIA binding to the Shaker 
channel.
1 The abbreviations used are: k-PVIIA. K-conotoxin PVIIA; HPLC. 
high performance liquid chromatography; WT, wild-type; fl. ohm; mut,
m utant.
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Fig. 1. M utation  o f th e  res idues 
H is" , A rg '8, L ys '9, and  A rg22 to  a la ­
n in e  re su lts  in  isoform s of K-eono- 
tox in  PVIIA th a t b lock th e  Sh a ker  K+ 
channel w ith  a  po tency  close to  the  
u n su b s titu ted  toxin. Whole cell cur­
rents recorded from oocytes expressing 
Shaker  H4 K 1 channels upon depolariza­
tion to 0. 20. and 40 mV are shown before 
(Control) and after addition of 1 /xm of the 
K-conotoxin isoform indicated. The hold­
ing potential was -1 0 0  mV. C urrents in 
the presence of toxin exhibit an  apparent 
slowing of the  activation/inactivation ki­
netics and an  increased steady sta te  cur­
rent. This is because of the  state-depend­










We have carried out a mutant cycle analysis of K-conotoxin 
PVIIA; the results identify a binding surface on the toxin that 
is clearly critical for high affinity K+ channel blocking and 
provide functional evidence for evaluating the two hypotheses 
that were presented on the basis of structural information.
EXPERIMENTAL PROCEDURES
Solid-phase Peptide Synthesis—The protected peptide resin  was 
built using standard  Fmoc (/V-O-fluorenyDmethoxycarbonyl) chemistry 
as described previously (11) w ith side chains protected as follows: 
pentamethylchromasulfonyl (Arg). f-butyl (Hyp. Asp. and Ser). S-trityl 
(Asn. Gin. His. and Cys). and i-butoxycarbonyl (Lys). Protocols for the 
removal of peptide from resin. HPLC purification, and disulfide bridge 
formation have been detailed before (11). Under standard  glutathione 
oxidation conditions, native k-PVIIA folds into the biologically active 
form with >90% efficiency. Although some analogs folded with much 
lower efficiency, the  correctly folded isomer was often well separated 
from other isomers during HPLC purification, m aking identification of 
the correctly folded form straightforward. Electrospray m ass spectros­
copy was carried out on all peptide analogs to confirm correct synthesis.
Verification by N M R and Circular Dichroism I CD)—One isoform. 
Asn21-Ala. could not be properly folded, and two other isoforms. Hyp1-  
Ala and Asn5-Ala. showed m uch reduced block bu t were obtained in 
yields th a t were insufficient for complete testing. M ultiple substitutions 
for Arg2. Lys7. and Phe9 were synthesized and folded (Arg2-Ala. Arg2-  
Gln. Arg2—Lys, Lys7-Ala. Lys7-Arg. Phe9-Ala. Phe9-M et. and Phe9-  
Tyr). The p a tte rn  of mixed folded isomers obtained for all analogs was 
very sim ilar to wild-type k-PVIIA. The earliest eluting major peak was 
collected and purified, and in  each case, presum ed to have the same 
disulfide connectivity as native PVIIA; one substitution for each of the 
three  loci (Arg2-Ala. Lys7-Ala. and Phe9-M et) was analyzed by NMR 
and CD to confirm directly th a t the  disulfide connectivity was native. 
However, I Iyp1 Ala. Asn5-Ala. Leu12-Ala. and Asp1'1 Ala were difficult 
to purify in high yield, and their structures have not been confirmed. 
The Leu12-A la analog in particular showed an  unusual p a tte rn  of 
isomers following folding and needs to be fu rther investigated.
Electrophysiological Measurements—The coding region of Shaker H4 
employed in  th is study was cloned into Bluescript vector. Point m u ta­
tions in the pore region were introduced by polymerase chain reaction 
m utagenesis, and the  amplified sequences were confirmed by sequenc­
ing. Capped cRNA was synthesized in vitro after linearizing the  plas­
mid with ifm d lll. and the  transcription with T7 RNA polymerase was 
performed by a standard  protocol (16).
Oocytes from Xenopus laevis were prepared as described previously 
(17. 18). Frogs were anesthetized with 0.2% tricaine in  ice w ater during 
surgery. cRNA coding for Shaker H4 was injected into oocytes, and the 
cells were incubated 1-7 days to allow expression of the protein. Prior 
to the electrophysiological m easurem ents the  vitelline m em branes of 
the oocytes were removed mechanically with fine forceps. Whole cell 
currents were recorded under two-electrode voltage clamp control using 
a Turbo-Tec amplifier (npi electronic. Tamm, Germany). The intracel­
lu lar electrodes were filled with 2 M KCl and had a resistance between 
0.6 and 1 Mil. C urrent records were low-pass filtered a t 1 kHz (—3 db) 
and sampled a t 4 kHz. The bath  solution was normal frog Ringer’s 
containing (in mM) the following: 115 NaCl. 2.5 KCl. 1.8 CaCl2. 10 
Hepes. pH 7.2 (NaOH).
To estim ate the  IC50 value of K-conotoxin PVIIA and the  correspond­
ing analogs, whole cell currents of oocytes expressing either wild-type
Table I
1CSB values for wild-type K-conotoxin PVIIA and analogs 
D ata shown represent m ean ± S.E. calculated from IC50 values 
independently determined for each cell (see “Experim ental Proce­
dures”); the num ber of independent experimental trails  are specified in 
the table, n.d.. not done.
Analog tcm Number of cells
PVIIA
JIM




I3A 170 ± 10 5
04A *o 2
N5A *o 1





F9Y 639 ± 101 4
Q10A 189 ± 3 4
H11A 183 ± 1 1 5
L12A *o 3
D13A 82 ± 5 5
D14A *o 3
S17A 86 ± 8 5
R18A 199 ± 10 6
K19A 69 ± 7 4
N21 n.d. n.d.
R22A 276 ± 12 5
F23A 993 ± 107 4
N24A 1066 ± 94 3
K25A 6663 ± 393 4
V27 n.d. n.d.
° These analogs gave very low yields upon folding, insufficient for an 
NMR analysis. The L12A analog in  particular had an  aberran t elution 
profile. All of these analogs were inactive (for 04A  and N5A. ICWP >
10.000 nM; for L12A and D14A. 1C5? >  50.000 nM). Although' the 
analogs were tested in the electrophysiological assay, because we were 
not able to obtain independent experimental evidence th a t these are 
properly folded, the  results should be interpreted with caution.
Shaker  H4 K 1 channel or m u tan t isoforms were recorded, and the  peak 
currents, a t a test voltage of 0 mV. were m easured. IC50 values were 
calculated according to IC50 = fc/(l -  fc) ■ [TxJ, w here/c is the  fractional 
current, and [TxJ is the toxin concentration applied. This is an approx­
im ation for calculating the affinity of the toxin for the  closed sta te  of the 
ion channel protein (19). Toxin concentrations were determined by 
assum ing th a t the  integrated absorbance (determined by HPLC) was 
equivalent for all analogs (1 /iimol = 33 A220 units) except for Ala 
substitution for aromatic residues, where this value was reduced by 
10%. The maximal toxin concentration tested for analogues of K-cono- 
toxin PVIIA th a t showed a low affinity to the Shaker  K 1 channel was 
usually 50 /xm. All electrophysiological experim ents were performed at 
room tem perature (19-22 °C).
M utant Cycle A?ialvsis—This method provides a m eans of revealing 
























described earlier (20. 21). Values for the coupling coefficient i l  were 
obtained by using the formula 12 = (IC50WTchannel:WTtoxin -ICgo 
mutchannel:muttoxin,)/(IC50W Tchannel:muttoxin ■ lC50m utchannel: 
WTtoxin). Unity reflects no interaction, whereas deviation from unity 
indicates progressively stronger interactions. For 12 <  1 the reciprocal 
is given for ease of comparison of their deviation from unity  (20,1. The 
change in coupling energy. AAG. for a given pair of toxin-channel 
residues was calculated according to AAG = RT In 12 (with R = 8.314 
•Jmol 1 and T = 295 KJ (20. 22,). The studies of Schreiber and Fersht 
(21,) suggest th a t a pair of residues showing a change in  AAG >  2.1 
kJ/mol 1 may be expected to lie within 5 A of each other (see also Ref.
23,).
RESULTS AND DISCUSSION 
Analogs of k-PVIIA containing alanine substitutions in each 
amino acid position of the peptide were synthesized and folded
Fig. 2. M utation  o f res idues Arg2, Lys7, and  P h e9 re su lts  in 
isoform s of K-conotoxin PVIIA th a t  do n o t block S h a ker  K+ 
channels. Whole cell currents recorded from oocytes expressing Shaker 
His4 K 1 channels are shown before (Control) and after addition of 20 or 
50 i.M of the  K-conotoxin PVIIA isoform indicated. The pulse protocol 
was as in Fig. 1.
(see “Experimental Procedures”), and the affinity of these iso­
forms was functionally assayed by electrophysiological meas­
urements using the Xenopus oocyte expression system. Fig. 1 
shows whole cell currents from oocytes expressing Shaker H4 
If" channels measured at different test potentials. Addition of 
1 /am  of four isoforms, Hisn -Ala, Arg18-Ala, Arg19-Ala, and 
Arg22-Ala, of K-conotoxin PVIIA leads to a block of the evoked 
currents of about 60 to 80%. Alanine substitutions of lie3, 
Gin10, Asp13, and Ser17 gave similar results. For these eight 
isoforms, the IC60 values were all within 5-fold of wild-type 
K-conotoxin PVIIA (see Table I). We note that some substitu­
tions (Ile3-Ala and Gln10-Ala, for example) cause a bigger 
change in the IC60 value than do others (such as Asp13-Ala, 
Ser17-Ala, and Lys19-Ala, which were all within 2-fold of wild- 
type PVIIA). Thus, residues such as lie3 or Gin10 could well 
make some contribution to the interaction of PVIIA with the 
Shaker channel, but this would be relatively minor compared 
with the residues discussed below.
In contrast to the mutations of the eight amino acid residues 
of K-conotoxin PVIIA described above, mutations of other resi­
dues resulted in a major reduction of the affinity for Shaker I f  
channels; the IC60 values of the different isoforms are summa­
rized in Table I. Examples of K-conotoxin PVIIA analogs that 
dramatically diminished activity are presented in Fig. 2. Be­
cause the alanine mutation at position 2 (Arg2-Ala) resulted in 
an isoform of K-conotoxin PVIIA that did not block the evoked 
Shaker I f  currents, this residue was also mutated to a lysine 
(Arg2-Lys), and the affinity of this isoform was investigated. 
The upper panel of Fig. 2 shows that even 20 /am  of the isoform 
Arg2-Lys of K-conotoxin PVIIA has almost no effect on the 
evoked Shaker currents. This demonstrates that even a 
charge-conserving substitution a t residue 2 of K-conotoxin 
PVIIA results in a profound reduction in toxin affinity, sug­
gesting that the arginine at this position is critically important 
for the interaction of the toxin with the channel protein. Sim­
ilar results were obtained with the alanine mutation of the 
lysine at position 7. The middle panel of Fig. 2 shows that even 
at a concentration of 50 /am  the Lys7-Ala isoform had almost no 
blocking effect on the evoked currents. The same results were 
obtained with mutations of the phenylalanine at position 9 
(Fig. 2, lower panel). Interestingly, even a conservative substi­
tution of phenylalanine to a tyrosine reduced the block by an 
order of magnitude (see Table I).
Fig. 3. A m odel o f th e  in te rac tio n  su rface  of K -conotoxin PVIIA. lied  indicates th a t the  1C50 value following alanine substitution in this 
position was >10 /xm, yellow  labels residues where alanine substitution resulted in  an  interm ediate 1C50 value (500 nM to 10 /xMj, and green labels 
residues where analogs had an  1C50 value w ithin 10-fold of the  native peptide (<500 nM), White residues were not substituted, could not be properly 
folded, or the relevant analogs were not available in  sufficient quantity  to verify proper folding (see the legend to Table 1). Cysteines are shown 


























Alanine mutations of the amino acid residues Gin8, Phe23, 
Asn24, and Lys26 exhibited an intermediate behavior in that 
the IC60 values of these isoforms were higher than 500 n M  but 
less than or near 10 /xm . A summary of the IC60 values of all 
isoforms tested is given in Table I.
Thus, the alanine walk mutagenesis of K-conotoxin PVIIA 
has identified several residues critical for functional block of 
the Shaker channel. A diagrammatic representation of the 
most important residues is shown in Fig. 3. The critical resi­
dues are colored red, and it is immediately apparent that these 
are adjacent to each other in the three-dimensional structure, 
though not in the primary amino acid sequence. The toxin 
surface, which presumably interacts with the outer vestibule of 
the Shaker pore to cause a channel block, is strongly suggested 
by our study to contain Arg2, Lys7, and Phe9 as key amino 
acids.
Two other positions, Leu12 and Asp14, may also play a critical 
role in K-FVIIA-Shaker interaction. As shown in Table I, the 
Leu12-Ala and Asp14-Ala analogs were inactive; however, the 
yields upon folding these analogs were very poor, and we were 
unable to obtain sufficient amounts to do an NMR analysis. For 
this reason, we have been conservative in our interpretation 
and have not colored these residues red in the model shown in 
Fig. 3. We note however that these are adjacent to the three 
confirmed critical residues on the toxin surface.
The differing predictions of Savarin et al. (13 ) and Scanlon et 
al. (12) can be compared using these results. Scanlon et al. (12) 
suggested that four positively charged residues in k-PVIIA 
were analogous to certain residues in charybdotoxin for inter­
action with the Shaker channel. A key residue in charybdotoxin 
is Lys27, which is postulated to directly occlude the pore of the 
channel (24); Scanlon et al. (12) suggested that the analogous 
position would be Lys19 of K-conotoxin PVIIA. Other charged 
residues that have been shown to be important in the charyb- 
dotoxin-SAa&er interaction are Arg26, Lys11, and Lys31 (25); the 
suggested analogous residues were Arg18, His11, and Arg22 of 
K-conotoxin.
The results of the alanine walk mutagenesis study described 
above do not support the postulated charybdotoxin analogy. In 
particular, the Lys19-Ala analog has an IC60 value for the 
Shaker channel close to that of the wild-type toxin. None of the 
other proposed residues show much change in IC60 when sub­
stituted by alanine; all gave values within a factor of 5 of the 
wild-type value and are among the residues represented in 
green in Fig. 3. The analogous placement of positive charges at 
the three-dimensional level between charybdotoxin and K-cono­
toxin PVIIA appears not to be functionally significant.
There were prior indications from electrophysiological work 
that some of the specific interactions of K-conotoxin PVIIA 
residues with outer vestibule amino acids of the Shaker chan­
nel pore were probably significantly different from charybdo- 
toxin-Shaker interactions. Most notably, the mutation Phe426-  
Gly on Shaker increases the affinity of charybdotoxin by 
~2,000-fold (26) but abolishes the binding of k-PVIIA at the 
concentrations tested (11). The conservative mutation Phe426-  
Tyr has close to wild-type k-PVIIA affinity, suggesting an im­
portant role for an aromatic residue at this position in the 
PVIIA-Shaker interaction.
Savarin et al. (13) postulated that, like other polypeptide 
toxins that are able to inhibit K+ channels, there may have 
been convergent evolution in one key feature of otherwise 
structurally unrelated toxins, the presence of a dyad consisting 
of a lysine residue (postulated to directly interact with the pore ) 
and a hydrophobic amino acid ( 2). Upon considering the various 
choices in K-conotoxin PVIIA, Savarin et al. (13) predicted that 
for K-conotoxin PVIIA the likely key residues were Lys7 and
Fig. 4. In fluence of single p o in t m u ta tio n s in  the  po re  reg ion  
of S h a ker  on k-PVIIA binding. The upper panel depicts the  amino 
acid alignm ent of the pore region of the Shaker  K channel (S5—S6 
linker) and the  corresponding region of the  bacterial K channel KcsA 
(28). Residues where point m utations in the  Shaker  K channel have 
been introduced are marked in bold. The bar diagram  shows the  affin­
ity of k-PVIIA to the individual channel m utants normalized to wild- 
type IC50. D ata represent mean ± S.E. (n = 3-9).
either Phe9 or Phe23 of k-PVIIA. Our results confirm that Lys7 
and Phe9 are indeed important for binding of K-conotoxin to the 
Shaker potassium channel ( and to a much lesser extent, so is 
Phe23 ). Another notable feature of the predictions of Savarin et 
al. (13) is a potential role for Lys26. This residue makes Van der 
Waals contact with Lys7 ( mean distance of aC atoms derived 
from NMR structure is 4.4 A), and an arrangement of two 
proximal lysine residues was compared with a similar motif in 
dendrotoxin that was found to have functional significance 
(27). We find that the Lys26 m utant has the most reduced 
affinity of the analogs in the intermediate group (those resi­
dues colored yellow in Fig. 3), with an IC60 value ~  100-fold 
higher than the wild-type peptide.
A number of pore mutations of the Shaker channel were 
generated, and affinities of PVIIA and PVIIA m utants were 
measured. The effects of these single amino acid substitutions 
on the affinity of wild-type PVIIA are shown in Fig. 4. The 
mutations Lys427-Asn and Lys427-Asp resulted in an increased 
affinity of PVIIA of a factor of ~2. Similar effects have been 
reported for Lys427-Glu (12). Several other mutations (Phe426-  
Gly, Thr449-Lys, Thr449-Tyr, Thr449-Gln (11), and Val461-Lys) 
were not sensitive to PVIIA and therefore were not useful for 
the cycling analysis. All other channel mutations led to a slight 
reduction of PVIIA affinity or had no measurable effect (see 
Fig. 4, lower panel).
The results of the m utant cycling analysis are shown in 
Table II and Fig. 5. The m utant PVIIA peptides (with single 
amino acid substitutions) were tested against twelve different 
m utant Shaker channel isoforms. In most cases, strong inter­
actions were not detected (the fi values were close to 1, and the 
coupling energy (AAG) was close to 0). However, some fi values 
obtained provide at least suggestive data for the orientation of 
the peptide in the postulated outer vestibule of the channel. 
The fi value for the Lys26-Ala (toxin )-Met448-Lys (channel) 
pair of 7.3, which is equivalent to a AAG value of 4.86 kJ/mol-1, 
indicates an interaction between these two residues. Lys26 is 
close to Phe9 on the toxin molecule ( distance of the aC atoms is 
~8 A). The interaction between Lys26 and Met448 makes the 
relatively modest fi value of 2.7 for the Phe9-Tyr (toxin)- 
Thr449-S er (channel) pair potentially significant. Any other 
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AAG values are given in kJ/mol 
parentheses, n.d., not done.
Table II 
M utant Cycling Analysis
and were calculated as described under “Experim ental Procedures.” Num ber of experiments is given in
k-PVIIA mutants
Shaker mutants
S421K N423K S424K F425Y K427N K427D D431E D431N M448K T449S G452K G452E
I3A 0.07 (2) 0.18(2) 2.73 (4) 0.24 (2) n.d. 0.27 (3) n.d. 0.71(2) 0.22 (3) 1.70 (3) n.d. n.d.
Q6A 1.58(1) 0.04 (2) 2.06(2) 0.19(1) n.d. 0.20(2) n.d. 1.03 (2) 1.11 (2) 0.97 (2) n.d. n.d.
F9Y 0.26(1) 0.89 (2) 1.58(3) 0.82 (2) n.d. 0.33 (2) n.d. 0.14(2) 0.41 (3) 2.41 (4) n.d. n.d.
Q10A 0.07 (2) 0.24 (3) 0.03(1) 1.18(2) 0.23(1) 0.01(2) n.d. 0.41 (3) 0.24 (2) 2.25 (3) n.d. n.d.
D13A 0.02 (4) 1.17(4) 0.14(2) 0.90 (1) 1.23 (3) 0.65 (3) 0.05 (3) 0.37 (6) 1.13 (3) 0.38 (2) 0.67(2) 0.45(1)
R18A 0.37 (3) 1.02 (3) 1.12(2) 0.51(1) 0.47(2) 0.37 (3) 0.47 (2) 0.41 (5) 0.37 (2) 0.36 (2) 0.29(1) 0.71(1)
K19A 0.14(2) 0.47 (2) 0.21(2) 1.16(2) 1.44(2) 0.07(1) 0.36 (2) 0.41 (3) 0.06 (2) 0.14(1) 0.16(1) 1.29(1)
R22A 2.06 (4) 3.13 (4) 2.65 (4) 0.47 (2) n.d. 0.76(3) 0.08(1) 0.27 (2) 0.47 (2) 0.76 (2) n.d. 1.15(1)
F23A 2.18(2) 0.20(2) 2.53 (3) 1.50 (2) n.d. 0.77(3) n.d. 0.14(2) 0.84 (2) 1.50 (3) n.d. n.d.
N24A 0.81 (1) 0.39(1) 0.14(1) 0.82(1) n.d. 0.20(1) n.d. 0.54(1) 0.35 (2) 0.40 (1) n.d. n.d.









Fig. 5. M utan t cycling analysis of S h a ker  ch anne l and  k-PVIIA 
in te rac tion . A, examples for m utan t cycles of Shaker  Met'1'1^, with 
K-PVIIA-Lys“’ (indicating an interaction; 12 = 7.3) and K-PVIIA-Arg1'* 
(indicating no interaction; 12 = 1.2). IC50 values are given as mean ± 
S.E. B, bar diagram  showing a plot of the  12 values for different toxin (x 
axis) and channel (z axis) m utan t combinations (calculated as described 
under “Experim ental Procedures”). Pairs of residues showing a change 
in AAG >2.1 kJ/mol 1 are highlighted by an asterisk.
below detectable limits, and we were therefore constrained to 
using this conservative substitution (even the Phe9-M et sub­
stitution abolished detectable activity). This is suggestive evi­
dence tha t the key Thr449 residue, known to play a role in 
charybdotoxin binding, may be in close proximity to Phe9 of 
PVIIA. Thus, Phe9 of K-conotoxin PVIIA may be at a homolo­
gous locus in the vestibule to Tyr38 in charybdotoxin, i.e. the 
aromatic residue of the dyad postulated by Menez and co­
workers (2). This would therefore also make Phe9 analogous to 
Phe25 in KTX/AgTX and Tyr23 in Shk and Tyr28 in BgK (2, 22). 
The mean distance between the aC atom of Lys7 and the center 
of the benzene ring of Phe9 derived from the NMR structure
(13) is 8.3 A (range, 7.4-10.1 A). There also seems to be some 
interaction of Lys25 with Asp431 (ft 3.7).
The ft values obtained for the Arg22-Ala (toxin)-Asn423-Lys 
(channel) pair of 3.6 and the Ile3-Ala (toxin)-Ser424-Lys (chan­
nel) pair of 3.0 might indicate tha t there is also some interac­
tion of these residues. Unfortunately, because no substitution 
for Arg2 and Lys7 has been found that gives measurable affin­
ity, we were unable to carry out a m utant cycling analysis for 
these important loci. By using the spatial constraints that can 
be derived from the m utant cycle experiments, a docking of 
PVIIA into the KcsA crystal structure reveals that the docking 
configuration may fit with the m utant cycling data. An align­
ment of the residues that make up the pore regions of Shaker 
and KcsA is shown in the upper panel of Fig. 4. By assuming 
that Lys25 of k-PVIIA is in the vicinity of Leu81 (Met448 in 
Shaker), Phe9 of the toxin can be positioned close to Tyr82 
(Thr449) of the adjacent subunit of the channel pore vestibule 
(not shown). In this orientation, Lys7 of k-PVIIA is facing 
toward the ion channel pore. Furthermore, Arg22 of k-PVIIA is 
close to Gly58 (Asn423) and Ala57 (Ser424) of the same channel 
subunit with which Lys2° interacts, whereas lie3 of k-PVIIA is 
in the vicinity of Ala°7 (Ser424) of the channel opposite to that 
with which Phe9 interacts.
In summary, the data in this report do not support the 
predictions of Scanlon et al. (12) that there are positive residue 
homologies between PVIIA and charybdotoxin but are consist­
ent with the critical dyad hypothesis developed by Menez and 
co-workers (2) for polypeptide antagonists of voltage-gated K" 
channels.
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